Gene · 389
Papers2,557
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,557
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Protein Kinase C at the Crossroad of Mutations, Cancer, Targeted Therapy and Immune Response. | Biology (Basel) | 2023 | 37626933 | PubTator, text mining | PubMed |
| Unveiling the Performance of Cu-Water Nanofluid Flow with Melting Heat Transfer, MHD, and Thermal Radiation over a Stretching/Shrinking Sheet. | ACS Omega | 2023 | 37599919 | PubTator, text mining | PubMed |
| Navigating the landscape of Rho GTPase signalling system in autoimmunity: A bibliometric analysis spanning over three decades (1990 to 2023). | Cell Signal | 2023 | 37598919 | PubTator, text mining | PubMed |
| Opportunities and challenges of protein-based targeted protein degradation. | Chem Sci | 2023 | 37592990 | PubTator, text mining | PubMed |
| SDF-1 and NOTCH signaling in myogenic cell differentiation: the role of miRNA10a, 425, and 5100. | Stem Cell Res Ther | 2023 | 37582765 | PubTator, text mining | PubMed |
| Cross-family small GTPase ubiquitination by the intracellular pathogen Legionella pneumophila. | bioRxiv | 2023 | 37577546 | PubTator, text mining | PubMed |
| Statins in Cancer Prevention and Therapy. | Cancers (Basel) | 2023 | 37568764 | PubTator, text mining | PubMed |
| Integrative genetic and genomic networks identify microRNA associated with COPD and ILD. | Sci Rep | 2023 | 37567908 | PubTator, text mining | PubMed |
| Cellular mechanotransduction in health and diseases: from molecular mechanism to therapeutic targets. | Signal Transduct Target Ther | 2023 | 37518181 | PubTator, text mining | PubMed |
| The Role of miRNAs in the Development, Proliferation, and Progression of Endometrial Cancer. | Int J Mol Sci | 2023 | 37511248 | PubTator, text mining | PubMed |
| CXCL12-CXCR4/CXCR7 Axis in Cancer: from Mechanisms to Clinical Applications. | Int J Biol Sci | 2023 | 37497001 | PubTator, text mining | PubMed |
| Involvement of lncRNAs in cancer cells migration, invasion and metastasis: cytoskeleton and ECM crosstalk. | J Exp Clin Cancer Res | 2023 | 37464436 | PubTator, text mining | PubMed |
| Opto-RhoGEFs, an optimized optogenetic toolbox to reversibly control Rho GTPase activity on a global to subcellular scale, enabling precise control over vascular endothelial barrier strength. | Elife | 2023 | 37449837 | PubTator, text mining | PubMed |
| Co-administration of temozolomide (TMZ) and the experimental therapeutic targeting miR-10b, profoundly affects the tumorigenic phenotype of human glioblastoma cells. | Front Mol Biosci | 2023 | 37398551 | PubTator, text mining | PubMed |
| Shear Stress Drives the Cleavage Activation of Protease-Activated Receptor 2 by PRSS3/Mesotrypsin to Promote Invasion and Metastasis of Circulating Lung Cancer Cells. | Adv Sci (Weinh) | 2023 | 37395651 | PubTator, text mining | PubMed |
| Roles of non-coding RNAs in intercellular crosstalk in cardiovascular diseases. | Korean J Physiol Pharmacol | 2023 | 37386827 | PubTator, text mining | PubMed |
| Transcriptional and chromatin profiling of human blood innate lymphoid cell subsets sheds light on HIV-1 pathogenesis. | EMBO J | 2023 | 37382276 | PubTator, text mining | PubMed |
| Onco-Pathogen Mediated Cancer Progression and Associated Signaling Pathways in Cancer Development. | Pathogens | 2023 | 37375460 | PubTator, text mining | PubMed |
| The Intricate Interplay between Cancer Stem Cells and Oncogenic miRNAs in Breast Cancer Progression and Metastasis. | Life (Basel) | 2023 | 37374142 | PubTator, text mining | PubMed |
| High Rate of Mutations of Adhesion Molecules and Extracellular Matrix Glycoproteins in Patients with Adult-Onset Focal and Segmental Glomerulosclerosis. | Biomedicines | 2023 | 37371859 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/389/papers?page=7